Stuart A Arbuckle Insider Trading for November 2015
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Stuart A Arbuckle.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Overview of insider trading of Stuart A Arbuckle for November 2015.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov 18 2015 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Option Exercise | M | 77.31 | 3,650 | 282,182 | 38,250 | |
| Nov 18 2015 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Sell | S | 124.00 | 3,650 | 452,600 | 104,464 | 108.1 K to 104.5 K (-3.38 %) |
| Nov 18 2015 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Sell | S | 123.00 | 100 | 12,300 | 108,114 | 108.2 K to 108.1 K (-0.09 %) |
| Nov 18 2015 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Sell | S | 122.47 | 143 | 17,513 | 108,214 | 108.4 K to 108.2 K (-0.13 %) |
| Nov 18 2015 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Sell | S | 121.95 | 184 | 22,439 | 108,357 | 108.5 K to 108.4 K (-0.17 %) |
| Nov 18 2015 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Buy | M | 77.31 | 3,650 | 282,182 | 108,541 | 104.9 K to 108.5 K (+3.48 %) |
| Nov 09 2015 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Option Exercise | M | 77.31 | 600 | 46,386 | 41,900 | |
| Nov 09 2015 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Option Exercise | M | 45.11 | 5,664 | 255,503 | 28,320 | |
| Nov 09 2015 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Sell | S | 125.17 | 200 | 25,034 | 104,748 | 104.9 K to 104.7 K (-0.19 %) |
| Nov 09 2015 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Sell | S | 124.59 | 1,220 | 152,000 | 104,948 | 106.2 K to 104.9 K (-1.15 %) |
| Nov 09 2015 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Sell | S | 123.04 | 2,400 | 295,296 | 106,168 | 108.6 K to 106.2 K (-2.21 %) |
| Nov 09 2015 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Sell | S | 122.46 | 2,444 | 299,292 | 108,568 | 111 K to 108.6 K (-2.20 %) |
| Nov 09 2015 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Buy | M | 77.31 | 600 | 46,386 | 111,012 | 110.4 K to 111 K (+0.54 %) |
| Nov 09 2015 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Buy | M | 45.11 | 5,664 | 255,503 | 110,412 | 104.7 K to 110.4 K (+5.41 %) |
| Nov 03 2015 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Sell | S | 126.31 | 4,500 | 568,395 | 104,748 | 109.2 K to 104.7 K (-4.12 %) |
| Nov 03 2015 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Sell | S | 125.30 | 3,950 | 494,935 | 109,248 | 113.2 K to 109.2 K (-3.49 %) |
| Nov 03 2015 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Sell | S | 124.44 | 1,000 | 124,440 | 113,198 | 114.2 K to 113.2 K (-0.88 %) |
| Nov 03 2015 | VRTX | VERTEX PHARMACEUTI ... | Arbuckle Stuart A | EVP\Chief Commercia ... | Sell | S | 123.36 | 900 | 111,024 | 114,198 | 115.1 K to 114.2 K (-0.78 %) |